Ballentine Partners’s Microchip Technology MCHP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$352K Sell
3,865
-1,786
-32% -$159K ﹤0.01% 710
2026
Q1
$365K Buy
+5,651
New +$406K 0.01% 647
2025
Q4
Sell
-3,119
Closed -$200K 1059
2025
Q3
$200K Sell
3,119
-7
-0.2% -$474 ﹤0.01% 924
2025
Q2
$220K Sell
3,126
-1,873
-37% -$103K ﹤0.01% 844
2025
Q1
$242K Buy
4,999
+286
+6% +$15.9K ﹤0.01% 706
2024
Q4
$270K Buy
4,713
+437
+10% +$30K ﹤0.01% 641
2024
Q3
$343K Sell
4,276
-797
-16% -$65.8K 0.01% 541
2024
Q2
$464K Buy
5,073
+1,829
+56% +$167K 0.01% 420
2024
Q1
$291K Buy
3,244
+50
+2% +$4.31K 0.01% 540
2023
Q4
$288K Sell
3,194
-154
-5% -$12.5K 0.01% 514
2023
Q3
$261K Buy
3,348
+316
+10% +$26.5K 0.01% 473
2023
Q2
$272K Sell
3,032
-100
-3% -$7.89K 0.01% 466
2023
Q1
$262K Buy
3,132
+160
+5% +$12.8K 0.01% 452
2022
Q4
$209K Buy
+2,972
New +$205K 0.01% 453

Other funds holding MCHP

Ballentine Partners's MCHP Position: Q2 2026 in Review

Ballentine Partners reduced its Microchip Technology (MCHP) stake by 32% in Q2 2026, selling an estimated $159K and leaving 3,865 shares worth $352K. The position accounts for ﹤0.01% of the portfolio, ranked #710.

Ballentine Partners first reported a position in MCHP in Q4 2022 and has held it in 14 quarters since. The position peaked at $464K in Q2 2024. 221 funds tracked by Wall St. Rank hold MCHP as of Q2 2026.

  • Ballentine Partners held 3,865 shares of Microchip Technology worth $352K as of Q2 2026.
  • Ballentine Partners sold 1,786 Microchip Technology shares in Q2 2026, an estimated $159K.
  • Microchip Technology made up ﹤0.01% of Ballentine Partners's portfolio in Q2 2026, its #710 holding.
  • Ballentine Partners first reported a position in Microchip Technology in Q4 2022 and has held it in 14 quarters since.
  • Ballentine Partners's Microchip Technology position peaked at $464K in Q2 2024.
  • 221 funds tracked by Wall St. Rank held Microchip Technology as of Q2 2026.

Based on Ballentine Partners's 13F filing for Q2 2026, filed 17 Jul 2026.